Login / Signup

Botulinum Toxin Injection and Electromyography in Patients Receiving Anticoagulants: A Systematic Review.

Yeow Leng TanTze Chao Wee
Published in: PM & R : the journal of injury, function, and rehabilitation (2020)
Despite the varied practice in anticoagulated patients undergoing BTX or EMG, practitioners should allow periprocedural continuation of anticoagulants, targeting an INR of 2 to 3 while using the smallest needle (25 gauge or smaller) of appropriate length. Some of the evidence on procedural guidance and complication surveillance were weak and more research in these areas is required.
Keyphrases
  • botulinum toxin
  • ultrasound guided
  • patients undergoing
  • primary care
  • public health
  • healthcare
  • percutaneous coronary intervention
  • cancer therapy
  • high density
  • quality improvement
  • upper limb
  • acute coronary syndrome